Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) shot up 0.3% on Friday . The company traded as high as $3.23 and last traded at $3.00. 14,194 shares traded hands during trading, a decline of 59% from the average session volume of 34,444 shares. The stock had previously closed at $2.99.
Conduit Pharmaceuticals Price Performance
The firm has a 50-day moving average price of $3.16 and a 200-day moving average price of $3.16.
Conduit Pharmaceuticals Company Profile
Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.
Featured Stories
- Five stocks we like better than Conduit Pharmaceuticals
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 4/29 – 5/3
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What does consumer price index measure?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Conduit Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conduit Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
